Amicus Therapeutics, Inc. (FOLD) Social Stream
AMICUS THERAPEUTICS INC (FOLD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering FOLD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 11 | $29 | $12 | $18.333 | $11.19 | 63.83% |
| 2021-11-15 | 10 | $29 | $12 | $18.444 | $11.19 | 64.83% |
| 2021-11-23 | 10 | $29 | $12 | $18.555 | $11.19 | 65.82% |
| 2022-01-13 | 9 | $29 | $12 | $17.375 | $11.19 | 55.27% |
| 2022-01-17 | 9 | $29 | $15 | $17.875 | $11.19 | 59.74% |
| 2022-01-26 | 9 | $29 | $15 | $17.5 | $11.19 | 56.39% |
| 2022-02-25 | 9 | $29 | $14 | $17 | $11.19 | 51.92% |
| 2022-04-20 | 9 | $20 | $14 | $15.5 | $11.19 | 38.52% |
| 2022-05-10 | 10 | $20 | $11 | $15 | $11.19 | 34.05% |
| 2022-05-12 | 10 | $20 | $11 | $15.222 | $11.19 | 36.03% |
| 2022-08-05 | 7 | $20 | $11 | $15 | $11.19 | 34.05% |
| 2022-08-13 | 7 | $20 | $11 | $15.142 | $11.19 | 35.32% |
The Trend in the Analyst Price Target
Over the past 19 months, FOLD's average price target has gone down $9.67.
FOLD reports an average of 71.57% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-25 | 9 | 29 | 14 | 17.000 | 8.25 | 106.06% |
| 2022-05-12 | 9 | 20 | 11 | 15.222 | 7.31 | 108.24% |
| 2022-05-12 | 8 | 20 | 11 | 15.222 | 7.31 | 108.24% |
| 2022-07-25 | 7 | 20 | 11 | 15.142 | 10.30 | 47.01% |
| 2022-08-12 | 7 | 20 | 11 | 15.142 | 12.32 | 22.91% |
FOLD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.29 | 6 | 0 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 24 months, FOLD's average broker recommendation rating improved by 0.13.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- FOLD has a greater average analyst price target than 354.74% of all US stocks.
- In terms of how AMICUS THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1292.9% of that group.
- In terms of how AMICUS THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 383.12% of that group.
- In terms of how AMICUS THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 1331.78% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AMICUS THERAPEUTICS INC are FGEN, EVO, and ESPR.
View All Top Stocks by Price Target
What is the outlook for FOLD? Use POWR Ratings for clearer insight into price direction.